Abstract
Conception, pregnancy and childbirth are a biological necessity, a unique privilege and birthright and yet something that mothers suffering with vasculitis cannot take for granted. Takayasu arteritis and Behcet’s disease mainly, but also ANCA associated vasculitis and IgA vasculitis are of relevance in this population. A diagnosis of systemic vasculitis has meant a lower chance of stable relationships, lower fertility, lower conception rates and worse foetal outcomes. Systemic vasculitis or it’s treatment may affect fertility by direct involvement of the reproductive organs, teratogenicity, induced infertility, or by producing a state inducing an inability of the maternal body to carry a foetus to term. Unfortunately, there is sometimes the need for medical termination. Pregnancy outcomes are poorer in women with a diagnosis of vasculitis, but this may be truer for women with Takayasu arteritis than Behcet’s disease. In spite of the many challenges in looking after expectant mothers with systemic vasculitis, we suggest some basic principles in this chapter to improve maternal and foetal outcomes. This is largely an evidence-free zone and this stream of medicine involving motherhood, babies and life-threatening rare diseases will remain emotive and therefore difficult, calling for the best that clinicians can offer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11
Guillevin L, Mukhtyar C, Pagnoux C, Yates M (2018) Conventional and biological immunosuppressants in vasculitis. Best Pract Res Clin Rheumatol 32(1):94–111
Mukhtyar C, Hellmich B, Jayne D, Flossmann O, Luqmani R (2006) Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Clin Exp Rheumatol 24(6):S93
Mukhtyar CB, Flossmann O, Luqmani RA (2006) Clinical and biological assessment in systemic necrotizing vasculitides. Clin Exp Rheumatol 24(2 Suppl 41):S92–S99
Walsh M, Mukhtyar C, Mahr A, Herlyn K, Luqmani R, Merkel PA et al (2011) Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res (Hoboken) 63(7):1055–1061
Pathak H, Mukhtyar C (2016) Pregnancy and systemic vasculitis. Indian J Rheumatol 11(6):145
McDuffie FC (1985) Morbidity impact of rheumatoid arthritis on society. Am J Med 78(1A):1–5
Pagnoux C, Mahendira D, Laskin CA (2013) Fertility and pregnancy in vasculitis. Best Pract Res Clin Rheumatol 27(1):79–94
MacLean MA, Wilson R, Thomson JA, Krishnamurthy S, Walker JJ (1992) Immunological changes in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 43(3):167–172
van der Horst-Bruinsma IE, de Vries RR, de Buck PD, van Schendel PW, Breedveld FC, Schreuder GM et al (1998) Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother. Ann Rheum Dis 57(5):286–290
Østensen M, Förger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM (2005) Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post-partum. Ann Rheum Dis 64(6):839–844
Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14(7):353–356
Kariv R, Sidi Y, Gur H (2000) Systemic vasculitis presenting as a tumorlike lesion. Four case reports and an analysis of 79 reported cases. Medicine (Baltimore) 79(6):349–359
Suo L, Perez LC, Finch CJ (2019) Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody-associated vasculitis patient. SAGE Open Med Case Rep 7. https://doi.org/10.1177/2050313X18823451
Barber TD, Al-Omar O, Poulik J, McLorie GA (2006) Testicular infarction in a 12-year-old boy with Wegener’s granulomatosis. Urology 67(4):846.e9–846.10
Rengasamy P (2017) Congenital malformations attributed to prenatal exposure to cyclophosphamide. Anti-Cancer Agents Med Chem 17(9):1211–1227
Clowse ME, Copland SC, Hsieh TC, Chow SC, Hoffman GS, Merkel PA et al (2011) Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res (Hoboken) 63(12):1777–1781
Slater CA, Liang MH, McCune JW, Christman GM, Laufer MR (1999) Preserving ovarian function in patients receiving cyclophosphamide. Lupus 8(1):3–10
Ding J, Shang X, Zhang Z, Jing H, Shao J, Fei Q et al (2017) FDA-approved medications that impair human spermatogenesis. Oncotarget 8(6):10714–10725
Kumar A, Mohan A, Gupta R, Singal VK, Garg OP (1998) Relapse of Wegener’s granulomatosis in the first trimester of pregnancy: a case report. Br J Rheumatol 37(3):331–333
Pagnoux C, Le Guern V, Goffinet F, Diot E, Limal N, Pannier E et al (2011) Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies. Rheumatology (Oxford) 50(5):953–961
Hidaka N, Yamanaka Y, Fujita Y, Fukushima K, Wake N (2012) Clinical manifestations of pregnancy in patients with Takayasu arteritis: experience from a single tertiary center. Arch Gynecol Obstet 285(2):377–385
Sangle SR, Vounotrypidis P, Briley A, Nel L, Lutalo PM, Sanchez-Fernandez S et al (2015) Pregnancy outcome in patients with systemic vasculitis: a single-centre matched case-control study. Rheumatology (Oxford) 54(9):1582–1586
Croft AP, Smith SW, Carr S, Youssouf S, Salama AD, Burns A et al (2015) Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis. Kidney Int 87(4):807–811
Jordan NP, Bezanahary H, D’Cruz DP (2015) Increased risk of vascular complications in Takayasu’s arteritis patients with positive lupus anticoagulant. Scand J Rheumatol 44(3):211–214
Flint J, Panchal S, Hurrell A, van de Venne M, Gayed M, Schreiber K et al (2016) BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 55(9):1693–1697
Mandal D, Mandal S, Dattaray C, Banerjee D, Ghosh P, Ghosh A et al (2012) Takayasu arteritis in pregnancy: an analysis from eastern India. Arch Gynecol Obstet 285(3):567–571
Comarmond C, Mirault T, Biard L, Nizard J, Lambert M, Wechsler B et al (2015) Takayasu arteritis and pregnancy. Arthritis Rheumatol 67(12):3262–3269
Ben-Chetrit E (2014) Behcet’s syndrome and pregnancy: course of the disease and pregnancy outcome. Clin Exp Rheumatol 32(4 Suppl 84):S93–S98
Noel N, Wechsler B, Nizard J, Costedoat-Chalumeau N, Boutin d LT, Dommergues M et al (2013) Behcet’s disease and pregnancy. Arthritis Rheum 65(9):2450–2456
Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T et al (2016) EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75(9):1583–1594
Dayoan ES, Dimen LL, Boylen CT (1998) Successful treatment of Wegener’s granulomatosis during pregnancy: a case report and review of the medical literature. Chest 113(3):836–838
Sangle SR, Lutalo PM, Davies RJ, Khamashta MA, D’Cruz DP (2013) B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. J Autoimmun 43:55–59
Diav-Citrin O, Otcheretianski-Volodarsky A, Shechtman S, Ornoy A (2014) Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. Reprod Toxicol 43:78–84
Jayne DR, Chapel H, Adu D, Misbah S, O’Donoghue D, Scott D et al (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93(7):433–439
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mashru, P., Mukhtyar, C. (2020). Pregnancy in Systemic Vasculitis. In: Sharma, S. (eds) Women's Health in Autoimmune Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-15-0114-2_14
Download citation
DOI: https://doi.org/10.1007/978-981-15-0114-2_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0113-5
Online ISBN: 978-981-15-0114-2
eBook Packages: MedicineMedicine (R0)